Human Gene RECK (uc003zyv.3)
  Description: Homo sapiens reversion-inducing-cysteine-rich protein with kazal motifs (RECK), mRNA.
RefSeq Summary (NM_021111): The protein encoded by this gene is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. In normal cells, this membrane-anchored glycoprotein may serve as a negative regulator for matrix metalloproteinase-9, a key enzyme involved in tumor invasion and metastasis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015].
Transcript (Including UTRs)
   Position: hg19 chr9:36,036,910-36,124,452 Size: 87,543 Total Exon Count: 21 Strand: +
Coding Region
   Position: hg19 chr9:36,036,996-36,123,042 Size: 86,047 Coding Exon Count: 21 

Page IndexSequence and LinksUniProtKB CommentsPrimersGenetic AssociationsMalaCards
CTDGene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein Structure
Other SpeciesGO AnnotationsmRNA DescriptionsPathwaysOther NamesModel Information
Methods
Data last updated at UCSC: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr9:36,036,910-36,124,452)mRNA (may differ from genome)Protein (971 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
GeneNetworkH-INVHGNCHPRDLynxMalacards
MGIneXtProtOMIMPubMedReactomeTreefam
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: RECK_HUMAN
DESCRIPTION: RecName: Full=Reversion-inducing cysteine-rich protein with Kazal motifs; Short=hRECK; AltName: Full=Suppressor of tumorigenicity 15 protein; Flags: Precursor;
FUNCTION: Negatively regulates matrix metalloproteinase-9 (MMP-9) by suppressing MMP-9 secretion and by direct inhibition of its enzymatic activity. RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis. Appears to also regulate MMP-2 and MT1-MMP, which are involved in cancer progression.
SUBUNIT: Interacts with MMP-9.
SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor.
TISSUE SPECIFICITY: Expressed in various tissues and untransformed cells. It is undetectable in tumor-derived cell lines and oncogenically transformed cells.
PTM: N-glycosylated.
SIMILARITY: Contains 3 Kazal-like domains.

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): RECK
CDC HuGE Published Literature: RECK

-  MalaCards Disease Associations
  MalaCards Gene Search: RECK
Diseases sorted by gene-association score: middle ear squamous cell carcinoma (10), middle ear carcinoma (3), wolfram syndrome (3), quebec platelet disorder (2), binswanger's disease (2), bone cancer (2), bone squamous cell carcinoma (2), colorectal cancer (1)

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 42.12 RPKM in Cells - Cultured fibroblasts
Total median expression: 243.12 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -46.7086-0.543 Picture PostScript Text
3' UTR -324.571410-0.230 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR011497 - Kazal-type_dom
IPR002350 - Prot_inh_Kazal

Pfam Domains:
PF07648 - Kazal-type serine protease inhibitor domain

SCOP Domains:
100895 - Kazal-type serine protease inhibitors

ModBase Predicted Comparative 3D Structure on O95980
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologGenome BrowserNo orthologNo ortholog
Gene Details  Gene Details  
Gene Sorter  Gene Sorter  
   FlyBase  
   Protein Sequence  
   Alignment  

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0004866 endopeptidase inhibitor activity
GO:0004867 serine-type endopeptidase inhibitor activity
GO:0005515 protein binding
GO:0008191 metalloendopeptidase inhibitor activity
GO:0030414 peptidase inhibitor activity

Biological Process:
GO:0001955 blood vessel maturation
GO:0007566 embryo implantation
GO:0010466 negative regulation of peptidase activity
GO:0030198 extracellular matrix organization
GO:0030336 negative regulation of cell migration
GO:0035115 embryonic forelimb morphogenesis
GO:1904684 negative regulation of metalloendopeptidase activity

Cellular Component:
GO:0005576 extracellular region
GO:0005886 plasma membrane
GO:0016020 membrane
GO:0031225 anchored component of membrane


-  Descriptions from all associated GenBank mRNAs
  AK292653 - Homo sapiens cDNA FLJ78129 complete cds, highly similar to Homo sapiens reversion-inducing-cysteine-rich protein with kazal motifs (RECK), mRNA.
D50406 - Homo sapiens ST15 mRNA, complete cds.
AK315073 - Homo sapiens cDNA, FLJ96027, highly similar to Homo sapiens reversion-inducing-cysteine-rich protein with kazal motifs (RECK), mRNA.
BC050306 - Homo sapiens reversion-inducing-cysteine-rich protein with kazal motifs, mRNA (cDNA clone IMAGE:4827696), with apparent retained intron.
BC032240 - Homo sapiens reversion-inducing-cysteine-rich protein with kazal motifs, mRNA (cDNA clone IMAGE:5212113), with apparent retained intron.
BC060806 - Homo sapiens reversion-inducing-cysteine-rich protein with kazal motifs, mRNA (cDNA clone IMAGE:30336414), complete cds.
BC137093 - Homo sapiens reversion-inducing-cysteine-rich protein with kazal motifs, mRNA (cDNA clone MGC:168713 IMAGE:9021090), complete cds.
CU687432 - Synthetic construct Homo sapiens gateway clone IMAGE:100020856 5' read RECK mRNA.
KJ901878 - Synthetic construct Homo sapiens clone ccsbBroadEn_11272 RECK gene, encodes complete protein.
JQ756320 - UNVERIFIED: Homo sapiens RECK mRNA, partial sequence.
JD462756 - Sequence 443780 from Patent EP1572962.
EF139848 - Homo sapiens clone 5-4 reversion-inducing cysteine-rich protein with Kazal motifs precursor splice variant (RECK) mRNA, partial sequence; alternatively spliced.
BX648668 - Homo sapiens mRNA; cDNA DKFZp686O2239 (from clone DKFZp686O2239).
JD104622 - Sequence 85646 from Patent EP1572962.
JD566046 - Sequence 547070 from Patent EP1572962.
JD329003 - Sequence 310027 from Patent EP1572962.
JD314836 - Sequence 295860 from Patent EP1572962.
JD045348 - Sequence 26372 from Patent EP1572962.
JD110900 - Sequence 91924 from Patent EP1572962.
JD090645 - Sequence 71669 from Patent EP1572962.
JD235830 - Sequence 216854 from Patent EP1572962.
JD196231 - Sequence 177255 from Patent EP1572962.
JD185748 - Sequence 166772 from Patent EP1572962.
JD311074 - Sequence 292098 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  BioCarta from NCI Cancer Genome Anatomy Project
h_reckPathway - Inhibition of Matrix Metalloproteinases

Reactome (by CSHL, EBI, and GO)

Protein O95980 (Reactome details) participates in the following event(s):

R-HSA-8940388 GPLD1 hydrolyses GPI-anchors from proteins
R-HSA-163125 Post-translational modification: synthesis of GPI-anchored proteins
R-HSA-597592 Post-translational protein modification
R-HSA-392499 Metabolism of proteins

-  Other Names for This Gene
  Alternate Gene Symbols: B2RNS1, NM_021111, NP_066934, O95980, Q5W0K6, Q8WX37, RECK_HUMAN, ST15
UCSC ID: uc003zyv.3
RefSeq Accession: NM_021111
Protein: O95980 (aka RECK_HUMAN)
CCDS: CCDS6597.1

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_021111.2
exon count: 21CDS single in 3' UTR: no RNA size: 4427
ORF size: 2916CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 6032.00frame shift in genome: no % Coverage: 99.66
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.